151 related articles for article (PubMed ID: 22170592)
21. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
[TBL] [Abstract][Full Text] [Related]
22. Influence of carboxylic acid functionalities in ruthenium (II) polypyridyl complexes on DNA binding, cytotoxicity and antioxidant activity: synthesis, structure and in vitro anticancer activity.
Sathiya Kamatchi T; Chitrapriya N; Kim SK; Fronczek FR; Natarajan K
Eur J Med Chem; 2013 Jan; 59():253-64. PubMed ID: 23234855
[TBL] [Abstract][Full Text] [Related]
23. High antitumor activity of 5,7-dihalo-8-quinolinolato tin(IV) complexes.
Chen ZF; Peng Y; Gu YQ; Liu YC; Liu M; Huang KB; Hu K; Liang H
Eur J Med Chem; 2013 Apr; 62():51-8. PubMed ID: 23353732
[TBL] [Abstract][Full Text] [Related]
24. New ruthenium(II)-letrozole complexes as anticancer therapeutics.
Castonguay A; Doucet C; Juhas M; Maysinger D
J Med Chem; 2012 Oct; 55(20):8799-806. PubMed ID: 22991922
[TBL] [Abstract][Full Text] [Related]
25. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
26. Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics.
Kouodom MN; Ronconi L; Celegato M; Nardon C; Marchiò L; Dou QP; Aldinucci D; Formaggio F; Fregona D
J Med Chem; 2012 Mar; 55(5):2212-26. PubMed ID: 22309237
[TBL] [Abstract][Full Text] [Related]
27. Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells.
Hackenberg F; Oehninger L; Alborzinia H; Can S; Kitanovic I; Geldmacher Y; Kokoschka M; Wölfl S; Ott I; Sheldrick WS
J Inorg Biochem; 2011 Jul; 105(7):991-9. PubMed ID: 21569751
[TBL] [Abstract][Full Text] [Related]
28. Non-classical anticancer agents: synthesis and biological evaluation of zinc(II) heteroleptic complexes.
Liguori PF; Valentini A; Palma M; Bellusci A; Bernardini S; Ghedini M; Panno ML; Pettinari C; Marchetti F; Crispini A; Pucci D
Dalton Trans; 2010 May; 39(17):4205-12. PubMed ID: 20390185
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(IV) dichloride and its complexes.
Shpakovsky DB; Banti CN; Beaulieu-Houle G; Kourkoumelis N; Manoli M; Manos MJ; Tasiopoulos AJ; Hadjikakou SK; Milaeva ER; Charalabopoulos K; Bakas T; Butler IS; Hadjiliadis N
Dalton Trans; 2012 Dec; 41(48):14568-82. PubMed ID: 23052471
[TBL] [Abstract][Full Text] [Related]
30. Structural studies and cytotoxic activity of N(4)-phenyl-2-benzoylpyridine thiosemicarbazone Sn(IV) complexes.
Perez-Rebolledo A; Ayala JD; de Lima GM; Marchini N; Bombieri G; Zani CL; Souza-Fagundes EM; Beraldo H
Eur J Med Chem; 2005 May; 40(5):467-72. PubMed ID: 15893020
[TBL] [Abstract][Full Text] [Related]
31. One pot synthesis of Cu(II) 2,2'-bipyridyl complexes of 5-hydroxy-hydurilic acid and alloxanic acid: synthesis, crystal structure, chemical nuclease activity and cytotoxicity.
Dixit N; Koiri RK; Maurya BK; Trigun SK; Höbartner C; Mishra L
J Inorg Biochem; 2011 Feb; 105(2):256-67. PubMed ID: 21194626
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of di-phenyl-tin(IV)-salicyliden-ortho-aminophenols: analysis of in vitro antitumor/antioxidant activities and molecular structures.
Beltrán HI; Damian-Zea C; Hernández-Ortega S; Nieto-Camacho A; Ramírez-Apan MT
J Inorg Biochem; 2007 Jul; 101(7):1070-85. PubMed ID: 17555822
[TBL] [Abstract][Full Text] [Related]
33. Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines.
Podeszwa B; Niedbala H; Polanski J; Musiol R; Tabak D; Finster J; Serafin K; Milczarek M; Wietrzyk J; Boryczka S; Mol W; Jampilek J; Dohnal J; Kalinowski DS; Richardson DR
Bioorg Med Chem Lett; 2007 Nov; 17(22):6138-41. PubMed ID: 17904844
[TBL] [Abstract][Full Text] [Related]
34. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
35. Ruthenium-arene complexes of curcumin: X-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-cymene)Ru(curcuminato)chloro.
Caruso F; Rossi M; Benson A; Opazo C; Freedman D; Monti E; Gariboldi MB; Shaulky J; Marchetti F; Pettinari R; Pettinari C
J Med Chem; 2012 Feb; 55(3):1072-81. PubMed ID: 22204522
[TBL] [Abstract][Full Text] [Related]
36. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
[TBL] [Abstract][Full Text] [Related]
37. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
[TBL] [Abstract][Full Text] [Related]
38. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.
Kovala-Demertzi D; Staninska M; Garcia-Santos I; Castineiras A; Demertzis MA
J Inorg Biochem; 2011 Sep; 105(9):1187-95. PubMed ID: 21718655
[TBL] [Abstract][Full Text] [Related]
40. Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.
Meker S; Manna CM; Peri D; Tshuva EY
Dalton Trans; 2011 Oct; 40(38):9802-9. PubMed ID: 21874187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]